{"id":"ivermectin-0-1-metronidazole-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation or burning"},{"rate":null,"effect":"Pruritus"},{"rate":null,"effect":"Erythema"},{"rate":null,"effect":"Metallic taste (if systemic absorption)"}]},"_chembl":{"chemblId":"CHEMBL6067487","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ivermectin binds to glutamate-gated chloride channels in parasites, causing paralysis and death. Metronidazole is a nitroimidazole that generates reactive oxygen species and damages DNA in anaerobic organisms. Together, they provide broad-spectrum activity against parasites and anaerobic bacteria, likely for topical or systemic treatment of mixed infections.","oneSentence":"This combination product uses ivermectin to paralyze parasites and metronidazole to disrupt microbial DNA, targeting parasitic and anaerobic bacterial infections.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:17:30.319Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parasitic and anaerobic bacterial skin infections (investigational)"}]},"trialDetails":[{"nctId":"NCT02236403","phase":"PHASE3","title":"Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%","status":"COMPLETED","sponsor":"Universidad Nacional de Colombia","startDate":"2014-10","conditions":"Chronic Blepharitis","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["22,23-dihydroavermectin B1a + 22,23-dihydroavermectin B1b"],"phase":"phase_3","status":"active","brandName":"Ivermectin 0.1% Metronidazole 1%","genericName":"Ivermectin 0.1% Metronidazole 1%","companyName":"Universidad Nacional de Colombia","companyId":"universidad-nacional-de-colombia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination product uses ivermectin to paralyze parasites and metronidazole to disrupt microbial DNA, targeting parasitic and anaerobic bacterial infections. Used for Parasitic and anaerobic bacterial skin infections (investigational).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}